In this study, the density of the synaptophysin-labeled presynaptic vesicle proteins in the axon terminals in the AM400 and AM600 groups was higher than that in the rats with scopolamine-induced AD-like symptoms, which is consistent with a previous study [12]. The gene discussed is PROS1; the disease is Alzheimer disease.